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Abstract 
A chief tripeptide antioxidant Glutathione (GSH) is present inside each body cell which may have a profound 
effect in the control of aging. The anti-aging potency of GSH and its role towards the progression of certain age-
related disease is still unclear. Glutathione based articles were searched on PubMEd database since the very first 
study of glutathione related to its discovery in 1923 to its present status till 2016. The data was made more 
informative and precise by searching glutathione relevant reports on google. Those articles were selected which 
were indicating the association of glutathione with the progression of age-related diseases, pre-clinical and 
clinical studies and age-longevity effect. It was analyzed that the increased oxidative stress (elevated 
GSSG/GSH ratio) is responsible for the incidence of age-related diseases and different organs failure. The 
glutathione redox ratio (GSSG/GSH) was found to be more pro-oxidizing with aging which plays a chief role 
for the generation of reactive oxygen species (ROS) and subsequently damages the macromolecular structures 
affecting the normal body mechanisms and functions. The clinical data has recommended that glutathione is a 
potent therapeutic agent for the control of age-related diseases and experimental analysis has confirmed its 
prominent effect in age-longevity.  In future, more research is required for the development of new GSH 
delivery systems, evaluation of GSH therapeutic efficacy and the direct effect of GSH supplementation in age 
longevity. GSH combinational therapy and increasing GSH bioavailability is an another area which can give 
promising results. 
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1. Introduction 
The incidence of age-related disorders proceeding to the organ failures is the foremost cause of deaths 
worldwide. Mortality as an outcome of aging is gaining research attention day by day. The diseases becoming 
more prevalent with aging includes osteoarthritis (OA), cataract, cardiac disorders, CNS (Central Nervous 
System) disorders, chronic renal disorders and reproductive disorders. Mortality is due to the development of 
various age related diseases or reduced performance of various organs. The mechanism underlying for the 
development of different age-related disorders and an effective therapeutic agent to control aging is still unclear. 
In the large number of available studies, the anti-oxidant potency of GSH has been widely reported, but its anti-
aging capability is still not highlighted. 
 Glutathione is actively synthesized by the animal cells and is present inside the cell at millimolar concentration. 
A remarkable decline in the intracellular antioxidant glutathione, most noticeably in brain, has been reported in 
several age-related diseases [1]. The aim of present review is to critically examine the evidences available for 
the prevalence of certain age-related diseases as an outcome of the harmful effects of increased glutathione 
related oxidative stress. 
2. Materials and methods 
Glutathione based articles were searched on PubMEd database using the keyword glutathione and reports were 
also searched on google. The present review has analyzed glutathione articles since the glutathione discovery in 
1921 to its present status till 2016. The current review is compiled after screening out numerous glutathione 
study reports. Those reports were excluded that were suggesting the role of glutathione in skin whitening. The 
selection criteria included those articles that indicated alterations in glutathione level with ageing and the organ 
which is most susceptible to glutathione antioxidant dysregulation as a subject of aging. The anti aging data was 
made more precise by analyzing several pre-clinical experimental reports where in the effect of glutathione in 
age longevity was checked. Trend in the number of published research articles in successive decades were also 
compared using PubMed database. 
3. Results 
The analysis of glutathione articles using the key word glutathione on PubMed database searched a total of 
1,29,680 articles. Those articles were screen out that were informative of the basic structure, properties and anti-
aging effect of glutathione with an earliest report on the glutathione constitution in the year 1923. The findings 
of glutathione articles on google suggested that, in 1921, glutathione was first reported as the autoxidisable 
constituent present inside the cell. The current review is stressing on those reports that have found glutathione as 
a master anti-aging agent and the age longevity pre-clinical studies. The progression of age-related diseases with 
aging has been consistently reported to be the outcome of the dysregulation in glutathione antioxidant system. 
An analysis done for the number of glutathione research articles published per decade on PubMed database 
found an increasing trend which is further indicating that glutathione is gaining more and more of research 
attention with time (Table 1). 
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Table 1: Table indicating the increasing trend of number of research articles published in the respective decade 
since the beginning of glutathione research 
Year range Number of articles published 
1928-1937 43 
1938-1947 42 
1948-1957 403 
1958-1967 1,435 
1968-1977 3,608 
1978-1987 9,177 
1988-1997 23,575 
1998-2007 42,054 
2008-2017 50,121 
 
Discovery, sources, basic structure and properties of Glutathione 
Glutathione was first identified as the autoxidisable constituent in the yeast cell and many animal tissues. It was 
initially analyzed as a dipeptide of glutamic acid and cysteine and found intracellular at a low concentration 
(0.01-0.02%) and its cysteine moiety is responsible for the reversible changes in sulfur group from sulphydryl to 
the disulphide condition [2]. A reinvestigation study revealed it to be a tri-peptide of glycine, glutamic acid and 
cysteine [3]. The common name of low molecular weight water-soluble thiol-tripeptide glutathione is γ-L-
Glutamyl-L-cysteinylglycine having chemical formula and molar mass of C10H17N3O6S and 
307.32 g·mol−1respectively.   
Modifications in glutathione redox state (increased oxidized glutathione (GSSG)/ GSH) as an outcome of 
aging 
A shift in the cellular glutathione redox state {reduced glutathione (GSH): oxidized glutathione (GSSG) ratio} 
towards more pro-oxidizing with aging has been reported in several studies. The GSSG content in mice has been 
found to be significantly increased to 84% with age, whereas the GSH content remained intact hence concluding 
a major alteration in glutathione redox state with aging [4]. 
Experimental Study attributing the role of GSH in age expansion  
The experimental data analyzed that on GCL over expression, the mean and maximum life spans of drosophila 
were increased with 50% [5]. This study significantly confirmed the age longevity effect of glutathione. 
Studies on the deleterious mechanisms with the age-related alteration in the glutathione  
Glutathione has reported to play a key role in defending the cell against the oxidative stress thereby acting as a 
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free radical scavenger. As compared with the young ones, the older persons have been analyzed with an 
increased oxidative stress as supported by a large number of studies. The protection of cell against ROS, such 
as, H2O2, hypochlorous acid (HClO), free radical superoxide (O2-2) and hydroxyl radical (-OH), is strongly 
hindered by the alteration in glutathione antioxidant system with aging, which further reduces the ability to 
prevent the progression of certain age-related diseases. The development of hydroxyl free radical is increased 
due to the variation in GSH antioxidant system which is responsible for the enhanced lipid peroxidation and rise 
in the level of products like, malondialdehyde and hydroxynonenals. These products form adducts with nucleic 
acids or proteins and their structure and functions get modified [6, 7]. Another consequence of GSH imbalance 
is the development of protein mixed disulfides which is responsible for the obstruction of catalytic efficiency of 
enzymes and thus hindering the adaptive responses stressful conditions [8, 9]. 
Evidences of age-related low GSH content (increased oxidative stress) leading to the progression of 
certain diseases prevalent with aging 
Age-related low GSH content leading to poor chondrocyte survival 
It has been reported that the human chondrocyte cells of younger donors survived significantly better than 
chondrocytes derived from older donors in addition to low GSSG/ GSH ratio in the cells of young donor, 
whereas the level of GSH indicated no significant difference in the cells of both the ages [10]. The extracellular 
matrix (ECM) is also reported to be adversely affected along with the reduced synthesis of proteoglycan and 
hyaluronic acid of articular cartilage due to the enhanced ROS production resulted with the reduced antioxidant 
capacity of the glutathione system. These only are the changes to be responsible for the development of 
osteoarthritis (OA), which becomes much more prevalent after the age of 50 [11, 12]. 
Age-related low glutathione content leading to cataract  
The concentration of the chief antioxidant molecule GSH in the eye lens is 2–4 mM and is required for the 
maintenance of clear lenses [13, 14]. The content of glutathione in mammalian eye is high which turns out to be 
low in cataract leading to immense suffering of the patient. The reduced synthesis and recycling of GSH and an 
elevated GSSG level is mainly investigated as the result of age-related fall in glutathione synthesis enzymes and 
glutathione reductase (GR) activity [15-19]. This is further responsible for the formation of human subcapsular 
cataract by making the cells more susceptible to oxidative damage by peroxide [20]. It has been observed that in 
vitro the single-strand breaks in chromosomal telomeres of human retinal pigment epithelial cells are induced by 
the oxidative stress [21]. Similarly, in a GSH-deficient transgenic mice the DNA strand breaks were developed 
on exposure to H2O2 [22, 23]. Such an amplified oxidative stress due to reduced GSH is the key initiating factor 
in the development of age-related cataracts which acts as a prominent cause of blindness worldwide. 
Age-related low glutathione content leading to heart diseases 
The age-related disturbances in glutathione antioxidant system are found to be capable of damaging the human 
heart and further leading to heart failure. In human atherosclerotic lesions, a weak glutathione-related enzymatic 
antioxidant shield is present which is affected with glutathione antioxidant system imbalance in vascular wall in 
International Journal of Sciences: Basic and Applied Research (IJSBAR)(2017) Volume 33, No  2, pp 257-265 
261 
 
human atherogenic processes [24]. It is also evidenced that there is a remarkable reduction in blood glutathione 
level before rise in TNFR1 (marker of symptomatic heart failure severity) in the patients of different heart 
diseases. 
This investigation recommended that blood glutathione test as a new biomarker to detect cardiac abnormalities 
cardiac abnormalities [25]. 
Age-related low glutathione content leading to Central Nervous System damage 
The variation in the glutathione antioxidant system is reported to be capable of causing the improper functioning 
of brain turning with the progression of diseases, such as, Alzheimer`s disease (AD), Parkinson`s disease (PD), 
Schizophrenia. Glutathione related oxidative stress has been found to play a prominent role in the development 
of brain diseases by dysfunction of protein, lipid, mitochondria, neurons; nucleic acid oxidation, impaired 
autophagy and further cell death. The chief reason behind the GSH deficiency in brain is the low level of 
glutathione peroxidase (GSH-Px) and superoxide dismutase (SOD) activity [26]. It is notably analyzed that PD 
is most primarily the outcome of glutathione depletion [27, 28]. In brain, the GSH loss is strongest and 
corresponded to the development of PD and neuronal injury following stroke [1]. 
Age-related low glutathione content leading to chronic renal failure 
The chronic renal failure (CRF) patients have consistently been reported with an oxidative stress as compared to 
healthy controls in several studies [29, 30] with a lower glutathione levels and reduced enzymatic activities of 
glutathione peroxidase and glutathione reductase [31]. 
Age-related low glutathione content leading to infertility  
The leading cause of infertility in the population of both men and women is the reproductive aging associated 
with reduced intracellular GSH level. On comparing with control the GSH concentrations in ollgozoospermla 
patients were significantly lower and causing male infertility [32, 33]. The deleterious effects of increased 
oxidative stress with aging involved affected cytoskeletal fibres, fertilization and embryo development [34]. 
Glutathione is crucial for the antioxidant defenses of spermatogenic epithelium, the epididymis and ejaculated 
spermatozoa [35]. Glutathione has been found to exhibit significant therapeutic effect on dyspermia associated 
with some andrological pathologies causing male infertility [36]. 
In addition, female infertility involving the cessation of ovarian follicular activity and poor pregnancy outcome 
is also found to be an outcome of the oxidative stress. The perimenopausal and postmenopausal phases as 
compared to the reproductive phase have been found to be associated with reduced GSH levels and enzymatic 
activities of GSH-Px, and SOD [37]. The hormonal therapy provided to post-menopausal women reduced the 
level of oxidative stress [38, 39]. 
The data available has led to the clear conclusion that reduced GSH level is the leading cause of infertility or 
reproductive aging in both the genders. GSH decrease in men is responsible for the diseases associated with 
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male infertility and in female responsible for the hormonal disorders. 
Clinical studies proving the therapeutic role of glutathione 
Glutathione has been clinically proven as an effective therapeutic agent in a large number of studies. The 
progression of Parkinson`s disease is effectively retarded by the intravenous administration of GSH [40]. In 
non—insulin-dependent diabetes mellitus patients, the total glucose uptake and both intra erythrocytic 
GSH/GSSG ratio were significantly increased by intravenous GSH infusion [41]. The patients of dyspermia 
were also positively cured by GSH [42]. Various skin inflammatory diseases like psoriasis have been 
recommended with the treatment of GSH [43]. In addition, TER286 and TER199 are the two glutathione based 
compounds acting as a pro-drug for cancer chemotherapy [44, 45]. 
4. Discussion 
The present systematic review is highlighting glutathione as a chief anti-aging agent. A low content of 
glutathione is responsible for the progression of certain age-related diseases associated with heart, eye, 
reproductive, CNS, kidney, cartilage etc. leading to the organ failure and subsequent death. In view of such an 
efficient anti-oxidant, and thus, anti-aging capability of GSH, there is a requirement of new approaches of 
increasing the cellular GSH level for the prevention of certain age-related diseases. In this direction, more 
research is required for the development of new methods of external GSH delivery system so as to increase its 
bioavailability or by helping human cells to synthesize more GSH. Further studies on GSH combinational 
therapy are required to be carried out for an enhanced effect of different available approaches to prevent 
different diseases. In addition to this, new clinical studies are required to be carried out for understanding the 
clear role of GSH in preventing the progression of disease. Further, more clinical investigations are required 
pertaining to the direct effect of GSH supplementation in age longevity. Several clinical studies are also required 
to investigate the effect of GSH supplementation in immuno compromised patients and in slowing down the 
progression of several diseases for which proper treatment is not available. 
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